Skip to content
‹ Back to IndustriesHealthcare

Rising Cancer Diagnoses in Young Adults: Lifestyle Changes and Early Screenings can Lower Risks

Cancer diagnoses among young adults are rising, driven by environmental, behavioral, and genetic factors. Host Kevin Stevenson and Dr. Najeeb Al Hallak discuss the importance of early screenings—such as colonoscopies, mammograms, and genetic testing—in detecting cancer sooner in younger populations. Primary care physicians are identified as critical players in early detection and prevention efforts.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from I Don't Care on MarketScale.

By Kevin Stevenson · · Barbara Ann Karmanos Cancer InstituteCancer DetectionCancer PreventionDr. Najeeb Al Hallak
Share

Key takeaways

01

Cancer is increasingly being diagnosed in younger adults, making early screening more critical than ever.

02

Environmental and behavioral factors, alongside genetics, are contributing to the rise in early-onset cancers.

03

Primary care physicians play a pivotal role in recommending timely screenings such as colonoscopies, mammograms, and genetic tests.

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

In recent years, a troubling trend has emerged: a noticeable rise in cancer diagnoses among young adults. This discussion is particularly timely following the news of Princess Kate Middleton’s cancer diagnosis and the growing recognition that cancer is no longer a disease confined to older populations. Research indicates that environmental and behavioral factors, alongside genetics, may be contributing to this increase.

Cancer is no longer a disease confined to older populations.

Why is there an increase in cancer diagnoses among younger populations, and what screenings should be prioritized to detect it early?

In this episode of “I Don’t Care,” host Dr. Kevin Stevenson talks with Dr. Najeeb Al Hallak, the medical oncologist and co-leader of the gastrointestinal and neuroendocrine oncology multidisciplinary team at the Barbara Ann Karmanos Cancer Institute. They delve into the importance of early cancer screenings and how primary care physicians can play a pivotal role in early detection and prevention.

Main Points of Conversation:

  • The importance of early cancer screenings for young adults, especially for those with familial or genetic predispositions.
  • The impact of environmental and behavioral factors on cancer risk in younger populations.
  • Specific cancer screening recommendations for young adults, including colonoscopies, mammograms, and genetic testing.

Dr. Najeeb Al Hallak is a distinguished medical oncologist specializing in gastrointestinal cancers. He serves as an associate professor in oncology at Wayne State University and co-leads the gastrointestinal and neuroendocrine oncology multidisciplinary team at the Barbara Ann Karmanos Cancer Institute. His research focuses on gastrointestinal malignancies, clinical trials, and the development of new cancer treatments.

I Don't Care

Part of this channel

I Don't Care

Candid healthcare leadership conversations with Kevin Stevenson

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

Kevin Stevenson
Kevin StevensonTop Hospital Administrator & Healthcare COO, I Don't Care
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

TheraPanacea's CEO says software, not hardware, will scale radiotherapy

TheraPanacea's CEO says software, not hardware, will scale radiotherapy

TheraPanacea CEO Nikos Paragios said at ASTRO 2026 in Boston that vendor-agnostic AI software like ART-Plan can raise radiotherapy throughput on existing machines. A February 2025 Lancet Oncology study puts the global linac shortfall at 30%, with 36 of 181 countries owning no linac, limiting how far software alone can go.

  • 01A February 2025 Lancet Oncology study found a global median Linac Shortage Index of 130, a 30% capacity shortfall, and 36 of 181 countries with no linac at all.
  • 02Bundled adaptive systems already exist: Varian’s Ethos won FDA clearance in February 2020 and RaySearch demoed automated replanning at ASTRO, but buyers still need to validate acceptability and sign-off workflows.

Oct 29, 2026

Berg Insight expects 160 million home medical monitors in care programs by 2030

Berg Insight expects 160 million home medical monitors in care programs by 2030

Prescribed connected home medical monitors are forecast to grow from 92.7 million in 2025 to 159.7 million by 2030. Fastest growth is in diabetes, remote ECG and medication compliance, spread across many suppliers. Berg and IoT Business News argue value depends on integrating data into workflows.

  • 01159.7 million prescribed home medical monitors expected by 2030, growing at 11.5 percent annually from 92.7 million in 2025.
  • 02Sleep therapy is the largest connected segment, followed by diabetes with 19.5 million connections at end of 2025, with fastest future growth in diabetes, remote ECG and medication compliance monitoring.
  • 03Clinical value increasingly depends on integrating data across devices into workflows: vendors combine hardware, software, analytics and interoperability with existing healthcare systems.

Oct 26, 2026

Zocdoc's first acquisition in nearly 20 years is an insurance checker

Zocdoc's first acquisition in nearly 20 years is an insurance checker

Zocdoc has bought Sohar Health, its first acquisition in nearly 20 years. Sohar's software finds and verifies a patient's insurance coverage from a name and birth date. Zocdoc wants that check to work across its Care Access Network, which lets insurers, consumer apps and AI tools embed Zocdoc's clinician search and scheduling on their own websites and apps.

  • 01After nearly 20 years without an acquisition, Zocdoc's first purchase is the insurance check that sits between a patient's search and a booked appointment.
  • 02For practices that pay Zocdoc per booking, the sharper question is how often coverage verified at booking matches what the front desk confirms at check-in.

Oct 24, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Experts

Kevin Stevenson
Kevin Stevenson

Host, I Don't Care Podcast

I Don't Care

Kevin Stevenson is the host of 'I Don't Care,' a MarketScale podcast focused on the challenges facing healthcare executives and administrators. He engages with industry leaders to explore the logistics and operational solutions that support hospitals, urgent care centers, and telemedicine operators. Stevenson holds an MBA and is a Fellow of the American College of Healthcare Executives (FACHE).

DN
Dr. Najeeb Al Hallak

Medical Oncologist and Co-Leader, Gastrointestinal and Neuroendocrine Oncology Multidisciplinary Team

Barbara Ann Karmanos Cancer Institute / Wayne State University

Dr. Najeeb Al Hallak is a medical oncologist specializing in gastrointestinal cancers and serves as an associate professor in oncology at Wayne State University. He co-leads the gastrointestinal and neuroendocrine oncology multidisciplinary team at the Barbara Ann Karmanos Cancer Institute. His research focuses on gastrointestinal malignancies, clinical trials, and the development of new cancer treatments.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512